MARKET

PMD

PMD

Psychemedics
NASDAQ

Real-time Quotes | Nasdaq Last Sale

8.40
+0.27
+3.32%
After Hours: 8.45 +0.05 +0.60% 16:38 09/24 EDT
OPEN
8.05
PREV CLOSE
8.13
HIGH
8.60
LOW
8.05
VOLUME
67.97K
TURNOVER
--
52 WEEK HIGH
8.60
52 WEEK LOW
3.580
MARKET CAP
46.55M
P/E (TTM)
-32.3077
1D
5D
1M
3M
1Y
5Y
BRIEF-Psychemedics Says Entered Into Settlement Agreement To Resolve Contract Dispute
reuters.com · 2d ago
Peter H. Kamin On Sept. 23 Delivered Letter To Psychemedics Corp's Board Of Directors Stating That It Is Necessary For Psychemedics' Board To Consider Strategic Alternatives For The Benefit Of All Stockholders
-Reuters
Reuters · 2d ago
Monday's Marijuana Stock Movers
GAINERS: Rhinomed (OTC:RHNMF) shares closed up 10.77% at $0.29 with an estimated market cap of $73.9M.
Benzinga · 08/30 22:58
Cannabis Stocks: Today's Gainers and Losers
GAINERS: Item 9 Labs (OTC:INLB) shares closed up 13.64% at $2.5 with an estimated market cap of $230,523,802.
Benzinga · 08/30 22:52
58 Biggest Movers From Friday
Gainers Regencell Bioscience Holdings Limited (NASDAQ: RGC) shares climbed 204.1% to close at $19.16 on Friday. Regencell Bioscience reported partial exercise of underwriter’s over-allotment option.
Benzinga · 08/23 09:06
BRIEF-Psychemedics Corp Reports Q2 EPS Of $0.02
reuters.com · 08/10 22:02
-- Earnings Flash (PMD) PSYCHEMEDICS CORPORATION Reports Q2 Revenue $6.1M
MT Newswires · 08/10 17:24
Sundial Growers, MedMen, World Acceptance Among Top Cannabis Stock Movers On July 26, 2021
GAINERS: Khiron Life Sciences (OTC: KHRNF) shares closed up 10.23% at $0.25
Benzinga · 07/26 20:58
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of PMD. Analyze the recent business situations of Psychemedics through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
EPS
Institutional Holdings
Institutions: 49
Institutional Holdings: 2.21M
% Owned: 39.90%
Shares Outstanding: 5.54M
TypeInstitutionsShares
Increased
5
21.81K
New
1
15.86K
Decreased
11
66.08K
Sold Out
4
49.33K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Healthcare Facilities & Services
-0.84%
Healthcare Providers & Services
-0.36%
Key Executives
Chairman/Director/President/Chief Executive Officer
Raymond Kubacki
Executive Vice President
Charles Doucot
Vice President - Operations
Michael Schaffer
Vice President/Controller
Andrew Limbek
Independent Director
Harry Connick
Independent Director
Robyn Davis
Independent Director
Walter Tomenson
Independent Director
Fred Weinert
Declaration Date
Dividend Per Share
Ex-Div Date
02/11/2020
Dividend USD 0.18
02/20/2020
10/22/2019
Dividend USD 0.18
11/04/2019
07/23/2019
Dividend USD 0.18
08/05/2019
04/23/2019
Dividend USD 0.18
05/06/2019
03/04/2019
Dividend USD 0.18
03/13/2019
10/23/2018
Dividend USD 0.18
11/01/2018
07/24/2018
Dividend USD 0.18
08/06/2018
04/24/2018
Dividend USD 0.18
05/07/2018
03/07/2018
Dividend USD 0.15
03/16/2018
10/24/2017
Dividend USD 0.15
11/03/2017
08/02/2017
Dividend USD 0.15
08/10/2017
04/25/2017
Dividend USD 0.15
05/04/2017
02/06/2017
Dividend USD 0.15
02/14/2017
10/26/2016
Dividend USD 0.15
11/03/2016
07/26/2016
Dividend USD 0.15
08/03/2016
04/26/2016
Dividend USD 0.15
05/04/2016
02/10/2016
Dividend USD 0.15
02/18/2016
10/28/2015
Dividend USD 0.15
11/05/2015
07/28/2015
Dividend USD 0.15
08/05/2015
04/27/2015
Dividend USD 0.15
05/06/2015
About PMD
Psychemedics Corporation is a hair drug testing company. The Company provides testing services for the detection of drugs of abuse through the analysis of hair samples. The Company’s testing methods utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The Company customize its enzyme immunoassay (EIA) procedures to drug test hair samples. The Company provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, phenylcyclohexyl piperidine (PCP), amphetamines, opiates, synthetic cannabinoids, benzodiazepines, nicotine and fentanyl. The Company’s testing process is used by police departments, Federal Reserve Banks, schools, and other public entities

Webull offers kinds of Psychemedics Corp. stock information, including NASDAQ:PMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PMD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PMD stock methods without spending real money on the virtual paper trading platform.